<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:ifp="http://www.ifactory.com/press" ifp-element-xpath="/*[local-name() = 'urlset' and namespace-uri() = 'http://www.sitemaps.org/schemas/sitemap/0.9']"><ifp:contentType>ARTICLE</ifp:contentType><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p255.xml</sm:loc><ifp:title>NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p255.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p249.xml</sm:loc><ifp:title>BRAF Inhibition in BRAF
         V600E-Positive Anaplastic Thyroid Carcinoma</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p249.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>BRAF Inhibition in BRAF
         V600E-Positive Anaplastic Thyroid Carcinoma</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-pxxxiv.xml</sm:loc><ifp:title>NCCN News</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-pxxxiv.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN News</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p241.xml</sm:loc><ifp:title>Somatostatin Analogues in Neuroendocrine Tumors</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p241.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Somatostatin Analogues in Neuroendocrine Tumors</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-plxvi.xml</sm:loc><ifp:title>Re: “Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course”</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-plxvi.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Re: “Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course”</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p237.xml</sm:loc><ifp:title>Promising the Moon!</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p237.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Promising the Moon!</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-pxlviii.xml</sm:loc><ifp:title>Oncology Research Program</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-pxlviii.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Oncology Research Program</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p265.xml</sm:loc><ifp:title>NCCN Work Group Report: Emerging Issues in Tissue Allocation</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p265.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN Work Group Report: Emerging Issues in Tissue Allocation</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p279.xml</sm:loc><ifp:title>Outcome Assessments and Cost Avoidance of an Oral Chemotherapy Management Clinic</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p279.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Outcome Assessments and Cost Avoidance of an Oral Chemotherapy Management Clinic</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p355.xml</sm:loc><ifp:title>Fertility Preservation in Patients With Breast Cancer: Necessity, Methods, and Safety</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p355.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Fertility Preservation in Patients With Breast Cancer: Necessity, Methods, and Safety</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p324.xml</sm:loc><ifp:title>Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p324.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p311.xml</sm:loc><ifp:title>A Discrete Choice Experiment to Examine the Preferences of Patients With Cancer and Their Willingness to Pay for Different Types of Health Care Appointments</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p311.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>A Discrete Choice Experiment to Examine the Preferences of Patients With Cancer and Their Willingness to Pay for Different Types of Health Care Appointments</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p291.xml</sm:loc><ifp:title>Use of Palliative Chemotherapy for Advanced Bladder Cancer: Patterns of Care in Routine Clinical Practice</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p291.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Use of Palliative Chemotherapy for Advanced Bladder Cancer: Patterns of Care in Routine Clinical Practice</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p301.xml</sm:loc><ifp:title>Documentation of Fertility Preservation Discussions for Young Adults With Cancer: Examining Compliance With Treatment Guidelines</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p301.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Documentation of Fertility Preservation Discussions for Young Adults With Cancer: Examining Compliance With Treatment Guidelines</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p365.xml</sm:loc><ifp:title>How Should Research Be Funded? Difficulties With the Argument for Proportionality to Causes of Death or Years of Life Lost</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/3/article-p365.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>How Should Research Be Funded? Difficulties With the Argument for Proportionality to Causes of Death or Years of Life Lost</ifp:title></sm:url></urlset>
